In this week’s edition of InnovationRx, we look at cheaper biologic drugs, Novo Nordisk’s $2 billion next-gen obesity drug ...

In a recently published review, a research team led by MedUni Vienna has highlighted a promising new approach to drug ...

New FDA guidelines for personalized genomic drug development are a step forward in advancing new therapies for ultrarare ...

Molecule AI is revolutionising drug discovery by using artificial intelligence to predict molecular combinations and ...

STOCKHOLM, Sweden, March 3, 2026. KDventures AB (Nasdaq Stockholm: KDV) today announces that Organon has discontinued the development of a preclinical drug candidate for polycystic ovarian syndrome ...

GPCRs are the targets for around one third of all approved drugs 1. Yet such medicines act on only a handful of the 800+ known GPCRs. A wave of biomedical progress in the early 21 st century thrust ...

Belgian drugmaker UCB has entered into an agreement to licence Antengene's experimental autoimmune disease therapy ATG-201 ...

The EMA and FDA have published a set of 10 'common principles' that should be taken into account when using AI in the development of medicines. The list has emerged as the adoption of AI among ...

The ambitious task on hand is apparent from the weighty title of the report – ‘Landscape Analysis on Alternatives to Animal Testing for Drug Development in India.’ That the report has the foreword by ...

Dr. Meng’s recognition follows last year’s Polanyi Prize in Chemistry awarded to Queen’s researcher Rachel Baker. Since 2007, five researchers in the Department of Chemistry have received the honour, ...

A blockbuster drug is a best-selling medication earning over $1 billion annually. Learn about them and how they revolutionize ...